Literature DB >> 25382023

Coding mutations in SORL1 and Alzheimer disease.

Badri N Vardarajan1, Yalun Zhang, Joseph H Lee, Rong Cheng, Christopher Bohm, Mahdi Ghani, Christiane Reitz, Dolly Reyes-Dumeyer, Yufeng Shen, Ekaterina Rogaeva, Peter St George-Hyslop, Richard Mayeux.   

Abstract

OBJECTIVE: Common single nucleotide polymorphisms in the SORL1 gene have been associated with late onset Alzheimer disease (LOAD), but causal variants have not been fully characterized nor has the mechanism been established. The study was undertaken to identify functional SORL1 mutations in patients with LOAD.
METHODS: This was a family- and cohort-based genetic association study. Caribbean Hispanics with familial and sporadic LOAD and similarly aged controls were recruited from the United States and the Dominican Republic, and patients with sporadic disease of Northern European origin were recruited from Canada. Prioritized coding variants in SORL1 were detected by targeted resequencing and validated by genotyping in additional family members and unrelated healthy controls. Variants transfected into human embryonic kidney 293 cell lines were tested for Aβ40 and Aβ42 secretion, and the amount of the amyloid precursor protein (APP) secreted at the cell surface was determined.
RESULTS: Seventeen coding exonic variants were significantly associated with disease. Two rare variants (rs117260922-E270K and rs143571823-T947M) with minor allele frequency (MAF) < 1% and 1 common variant (rs2298813-A528T) with MAF = 14.9% segregated within families and were deemed deleterious to the coding protein. Transfected cell lines showed increased Aβ40 and Aβ42 secretion for the rare variants (E270K and T947M) and increased Aβ42 secretion for the common variant (A528T). All mutants increased the amount of APP at the cell surface, although in slightly different ways, thereby failing to direct full-length APP into the retromer-recycling endosome pathway.
INTERPRETATION: Common and rare variants in SORL1 elevate the risk of LOAD by directly affecting APP processing, which in turn can result in increased Aβ40 and Aβ42 secretion.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25382023      PMCID: PMC4367199          DOI: 10.1002/ana.24305

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

1.  SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese.

Authors:  E K Tan; J Lee; C P Chen; Y Y Teo; Y Zhao; W L Lee
Journal:  Neurobiol Aging       Date:  2007-12-11       Impact factor: 4.673

2.  Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease.

Authors:  J H Lee; R Cheng; L S Honig; J-P G Vonsattel; L Clark; R Mayeux
Journal:  Neurology       Date:  2007-10-31       Impact factor: 9.910

3.  Detection of nonneutral substitution rates on mammalian phylogenies.

Authors:  Katherine S Pollard; Melissa J Hubisz; Kate R Rosenbloom; Adam Siepel
Journal:  Genome Res       Date:  2009-10-26       Impact factor: 9.043

4.  High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease.

Authors:  C Pottier; D Hannequin; S Coutant; A Rovelet-Lecrux; D Wallon; S Rousseau; S Legallic; C Paquet; S Bombois; J Pariente; C Thomas-Anterion; A Michon; B Croisile; F Etcharry-Bouyx; C Berr; J-F Dartigues; P Amouyel; H Dauchel; C Boutoleau-Bretonnière; C Thauvin; T Frebourg; J-C Lambert; D Campion
Journal:  Mol Psychiatry       Date:  2012-04-03       Impact factor: 15.992

5.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

6.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

7.  Association between SORL1 and Alzheimer's disease in a genome-wide study.

Authors:  Yan Meng; Joseph H Lee; Rong Cheng; Peter St George-Hyslop; Richard Mayeux; Lindsay A Farrer
Journal:  Neuroreport       Date:  2007-11-19       Impact factor: 1.837

Review 8.  The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Christiane Reitz
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

9.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.

Authors:  Joseph H Lee; Rong Cheng; Nicole Schupf; Jennifer Manly; Rafael Lantigua; Yaakov Stern; Ekaterina Rogaeva; Yosuke Wakutani; Lindsay Farrer; Peter St George-Hyslop; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  81 in total

1.  SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease.

Authors:  G Nicolas; C Charbonnier; D Wallon; O Quenez; C Bellenguez; B Grenier-Boley; S Rousseau; A-C Richard; A Rovelet-Lecrux; K Le Guennec; D Bacq; J-G Garnier; R Olaso; A Boland; V Meyer; J-F Deleuze; P Amouyel; H M Munter; G Bourque; M Lathrop; T Frebourg; R Redon; L Letenneur; J-F Dartigues; E Génin; J-C Lambert; D Hannequin; D Campion
Journal:  Mol Psychiatry       Date:  2015-08-25       Impact factor: 15.992

2.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 3.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

4.  Genetic epistasis regulates amyloid deposition in resilient aging.

Authors:  Daniel Felsky; Jishu Xu; Lori B Chibnik; Julie A Schneider; Jo Knight; James L Kennedy; David A Bennett; Philip L De Jager; Aristotle N Voineskos
Journal:  Alzheimers Dement       Date:  2017-03-17       Impact factor: 21.566

5.  SORL1 variants across Alzheimer's disease European American cohorts.

Authors:  Maria Victoria Fernández; Kathleen Black; David Carrell; Ben Saef; John Budde; Yuetiva Deming; Bill Howells; Jorge L Del-Aguila; Shengmei Ma; Catherine Bi; Joanne Norton; Rachel Chasse; John Morris; Alison Goate; Carlos Cruchaga
Journal:  Eur J Hum Genet       Date:  2016-09-21       Impact factor: 4.246

Review 6.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 7.  New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.

Authors:  Michael W Lutz; Donna Crenshaw; Kathleen A Welsh-Bohmer; Daniel K Burns; Allen D Roses
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 8.  Genetic variants in Alzheimer disease - molecular and brain network approaches.

Authors:  Chris Gaiteri; Sara Mostafavi; Christopher J Honey; Philip L De Jager; David A Bennett
Journal:  Nat Rev Neurol       Date:  2016-06-10       Impact factor: 42.937

Review 9.  Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer's Disease.

Authors:  Scott A Small; Sabrina Simoes-Spassov; Richard Mayeux; Gregory A Petsko
Journal:  Trends Neurosci       Date:  2017-10       Impact factor: 13.837

Review 10.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.